Photosystem II inhibition by moderate light under low temperature in intact leaves of chilling-sensitive and -tolerant plants

Photosystem II (PSII) activity was examsined in leaves of chilling-sensitive cucumber ( Cucumis sativus L.), tomato ( Lycopersicum esculentum L.), and maize ( Zea mays L.), and in chilling-tolerant barley ( Hordeum vulgare L.) illuminated with moderate white light (300 µmol m⁻² s⁻¹) at 4°C using chlorophyll a fluorescence measurements. PSII activity was inhibited in leaves of all the four plants as suggested by the decline in F _v/ F _m, 1/ F _o − 1/ F _m, and F _v/ F _o values. The changes in initial fluorescence level ( F _o), F _v/ F _m, 1/ F _o − /1/ F _m, and F _v/ F _o ratios indicate a stronger PSII inhibition in cucumber, maize and tomato plants. The kinetics of chlorophyll a fluorescence rise showed complex changes in the magnitudes and rise of O-J, J-I, and I-P phases caused by photoinhibition. The selective suppression of the J-I phase of fluorescence rise kinetics provides evidence for weakened electron donation from the oxidizing side, whereas the accumulation of reduced Q_A suggests damage to the acceptor side of PSII. These findings imply that the process of chilling-induced photoinhibition involves damage to more than one site in the PSII complexes. Furthermore, comparative analyses of the decline in F _v/ F _o and photooxidation of P700 explicitly show that the extent of photoinhibitory damage to PSII and photosystem I is similar in leaves of cucumber plants grown at a low irradiance level.     

Tuning the beta-turn segment in designed peptide beta-hairpins: construction of a stable type I' beta-turn nucleus and hairpin-helix transition promoting segments

Designed octapeptides Boc-Leu-Val-Val-Aib-(D)Xxx-Leu-Val-Val-OMe ((D)Xxx = (D)Ala, 3a;(D)Val, 3c and (D)Pro, 5a) and Boc-Leu-Phe-Val-Aib-(D)Ala-Leu-Phe-Val-OMe (3b) have been investigated to construct models of a stable type I' beta-turn nucleated hairpin and to generate systems for investigating helix-hairpin conformational transitions. Peptide 5a, which contains a central Aib-(D)Pro segment, is shown to adopt a stable type I' beta-turn nucleated hairpin structure, stabilized by four cross-strand hydrogen bonds. The stability of the structure in diverse solvents is established by the observation of all diagnostic NOEs expected in a beta-hairpin conformation. Replacement of (D)Pro5 by (D)Ala/(D)Val (3a-c) results in sequences that form beta-hairpins in hydrogen bonding solvents like CD(3)OH and DMSO-d(6). However, in CDCl(3) evidence for population of helical conformations is obtained. Peptide 6b (Boc-Leu-Phe-Val-Aib-Aib-Leu-Phe-Val-OMe), which contains a centrally positioned Aib-Aib segment, provides a clear example of a system, which exhibits a helical conformation in CDCl(3) and a significant population of both helices and hairpins in CD(3)OH and DMSO-d(6). The coexistence of multiple conformations is established by the simultaneous observation of diagnostic NOEs. Control over stereochemistry of the central beta-turn permits generation of models for robust beta-hairpins and also for the construction of systems that may be used to probe helix-hairpin conformational transitions.     

Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity

In vitro selection technologies are an important means of affinity maturing antibodies to generate the optimal therapeutic profile for a particular disease target. Here, we describe the isolation of a parent antibody, KENB061 using phage display and solution phase selections with soluble biotinylated human IL-1R1. KENB061 was affinity matured using phage display and targeted mutagenesis of VH and VL CDR3 using NNS randomization. Affinity matured VHCDR3 and VLCDR3 library blocks were recombined and selected using phage and ribosome display protocol. A direct comparison of the phage and ribosome display antibodies generated was made to determine their functional characteristics.     

Physiological and metabolic responses to work in heat with graded hypohydration in tropical subjects

Studies were conducted on 25 healthy male volunteers aged 20-25 years drawn randomly from the tropical regions of India. The subjects initially underwent an 8 day heat acclimatization schedule with 2 hours moderate work in a climatic chamber at 45 degrees C DB and 30% RH. These heat acclimatized subjects were then hypohydrated to varying levels of body weight deficits, i.e. 1.3 +/- 0.03, 2.3 +/- 0.04 and 3.3 +/- 0.04%, by a combination of water restriction and moderate exercise inside the hot chamber. After 2 hours rest in a thermoneutral room (25 +/- 1 degree C) the hypohydrated subjects were tested on a bicycle ergometer at a fixed submaximal work rate (40 W, 40 min) in a hot dry condition (45 degrees C DB, 30% RH, 34 degrees C WBGT). Significant increases in exercise heart rate and oral temperature were observed in hypohydrated subjects as compared to euhydration. Sweat rate increased with 1% and 2% hypohydration as compared to euhydration, but a significant decrease was observed with 3% hypohydration. Na+ & K+ concentrations in arm sweat increased with increase in the level of hypohydration. Oxygen consumption increased significantly only when hypohydration was about 2% or more. It appears that the increased physiological strain observed in tropical subjects working in heat with graded hypohydration is not solely due to reduced sweat rates.     

In silico assessment of drug safety in human heart applied to late sodium current blockers

Drug-induced action potential (AP) prolongation leading to Torsade de Pointes is a major concern for the development of anti-arrhythmic drugs. Nevertheless the development of improved anti-arrhythmic agents, some of which may block different channels, remains an important opportunity. Partial block of the late sodium current (I_NaL) has emerged as a novel anti-arrhythmic mechanism. It can be effective in the settings of free radical challenge or hypoxia. In addition, this approach can attenuate pro-arrhythmic effects of blocking the rapid delayed rectifying K⁺ current (I_Kr). The main goal of our computational work was to develop an in-silico tool for preclinical anti-arrhythmic drug safety assessment, by illustrating the impact of I_Kr/I_NaL ratio of steady-state block of drug candidates on “torsadogenic” biomarkers. The O’Hara et al. AP model for human ventricular myocytes was used. Biomarkers for arrhythmic risk, i.e., AP duration, triangulation, reverse rate-dependence, transmural dispersion of repolarization and electrocardiogram QT intervals, were calculated using single myocyte and one-dimensional strand simulations. Predetermined amounts of block of I_NaL and I_Kr were evaluated. “Safety plots” were developed to illustrate the value of the specific biomarker for selected combinations of IC₅₀s for I_Kr and I_NaL of potential drugs. The reference biomarkers at baseline changed depending on the “drug” specificity for these two ion channel targets. Ranolazine and GS967 (a novel potent inhibitor of I_NaL) yielded a biomarker data set that is considered safe by standard regulatory criteria. This novel in-silico approach is useful for evaluating pro-arrhythmic potential of drugs and drug candidates in the human ventricle.